Canada Pension Plan Investment Board
PMVP icon

Canada Pension Plan Investment Board’s PMV Pharmaceuticals PMVP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-113,500
Closed -$1.62M – 1283
2022
Q2 		$1.62M Buy
+113,500
New +$1.65M ﹤0.01% 717

Other funds holding PMVP

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Canada Pension Plan Investment Board's PMVP Position: Q3 2022 in Review

Canada Pension Plan Investment Board sold out of PMV Pharmaceuticals (PMVP) in Q3 2022, closing a stake of 113,500 shares — an estimated $1.62M sold.

Canada Pension Plan Investment Board first reported a position in PMVP in Q2 2022 and held it in 1 quarter. The position peaked at $1.62M in Q2 2022. 120 funds tracked by Wall St. Rank hold PMVP as of Q3 2022.

  • Canada Pension Plan Investment Board reported no remaining PMV Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 113,500 PMV Pharmaceuticals shares in Q3 2022, an estimated $1.62M.
  • Canada Pension Plan Investment Board first reported a position in PMV Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's PMV Pharmaceuticals position peaked at $1.62M in Q2 2022.
  • 120 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2022, filed 14 Nov 2022.